Catherine "Cat" Jennings has been named President of Beckman Coulter Diagnostics, a Danaher company, according to an announcement.

In this role, Jennings will lead the company's strategic, operational and organizational priorities, applying a culture of continuous improvement to accelerate innovation, strengthen global impact and help laboratories and clinicians deliver better patient outcomes.

Jennings was selected for her more than 20 years of healthcare industry leadership experience and a proven track record of driving growth, innovation and transformation across global healthcare organizations. She joins Beckman Coulter Diagnostics from Boston Scientific, where she most recently served as President of Vascular Therapies, leading a global business of approximately $2 billion in annual revenue.

Jennings earned a Bachelor of Science in Biology from Georgetown University and a Master of Business Administration from the University of California, Los Angeles.

Visit Beckman Coulter for more information